BACKGROUND: Those with an Apolipoprotein APOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4. Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established. METHODS: All cause dementia and cognitive impairment without dementia (CIND) was determined over five follow up visits from 1998 to 2006 in an ongoing cohort of older Latinos. The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments. RESULTS: CRP was significantly lower among those with APOE4 than in those without. Among those with APOE4, CRP was associated with lower rates of combined dementia/CIND (HR: 0.60, 95% CL: 0.20-0.91, p=0.03) from a fully adjusted model. Among those with no APOE4, there was no effect of CRP on dementia/CIND rates (HR: 0.94, 95% CL: 0.67-1.33). CONCLUSIONS: Lower CRP in those with APOE4 may reflect immune effects of the APOE4 genotype. Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
BACKGROUND: Those with an ApolipoproteinAPOE4 allele (APOE4) have lower C-reactive protein (CRP) than those without APOE4. Whether APOE4 modifies the effects of CRP on rate of all cause dementia, cognitive impairment or Alzheimer's disease (AD) is not established. METHODS: All cause dementia and cognitive impairment without dementia (CIND) was determined over five follow up visits from 1998 to 2006 in an ongoing cohort of older Latinos. The association between high sensitivity CRP and dementia/CIND, all cause dementia and Alzheimer's disease by APOE4 status was examined in semi-parametric survival models with covariate adjustments. RESULTS:CRP was significantly lower among those with APOE4 than in those without. Among those with APOE4, CRP was associated with lower rates of combined dementia/CIND (HR: 0.60, 95% CL: 0.20-0.91, p=0.03) from a fully adjusted model. Among those with no APOE4, there was no effect of CRP on dementia/CIND rates (HR: 0.94, 95% CL: 0.67-1.33). CONCLUSIONS: Lower CRP in those with APOE4 may reflect immune effects of the APOE4 genotype. Higher CRP in those with APOE4 may be a marker of better immune function, leading to lower rate of dementia and AD.
Authors: M X Tang; P Cross; H Andrews; D M Jacobs; S Small; K Bell; C Merchant; R Lantigua; R Costa; Y Stern; R Mayeux Journal: Neurology Date: 2001-01-09 Impact factor: 9.910
Authors: R Gamboa; G Hernandez-Pacheco; R Hesiquio; J Zuñiga; F Massó; L F Montaño; M Ramos-Kuri; J Estrada; J Granados; G Vargas-Alarcón Journal: Hum Biol Date: 2000-12 Impact factor: 0.553
Authors: K Yaffe; K Lindquist; B W Penninx; E M Simonsick; M Pahor; S Kritchevsky; L Launer; L Kuller; S Rubin; T Harris Journal: Neurology Date: 2003-07-08 Impact factor: 9.910
Authors: Carol A Colton; Leila K Needham; Candice Brown; Danielle Cook; Karima Rasheed; James R Burke; Warren J Strittmatter; Donald E Schmechel; Michael P Vitek Journal: J Neuroimmunol Date: 2004-02 Impact factor: 3.478
Authors: Reinhold Schmidt; Helena Schmidt; J David Curb; Kamal Masaki; Lon R White; Lenore J Launer Journal: Ann Neurol Date: 2002-08 Impact factor: 10.422
Authors: Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman Journal: Clin Neuropsychol Date: 2015-05-15 Impact factor: 3.535
Authors: Thomas M van Himbergen; Alexa S Beiser; Masumi Ai; Sudha Seshadri; Seiko Otokozawa; Rhoda Au; Nuntakorn Thongtang; Philip A Wolf; Ernst J Schaefer Journal: Arch Neurol Date: 2012-05
Authors: Monisha Sharma; Annette L Fitzpatrick; Alice M Arnold; Gloria Chi; Oscar L Lopez; Nancy S Jenny; Steven T DeKosky Journal: J Am Geriatr Soc Date: 2016-06 Impact factor: 5.562
Authors: Lindsay M Miller; Nancy S Jenny; Andreea M Rawlings; Alice M Arnold; Annette L Fitzpatrick; Oscar L Lopez; Michelle C Odden Journal: J Gerontol A Biol Sci Med Sci Date: 2020-07-13 Impact factor: 6.053
Authors: Ulrika K Eriksson; Nancy L Pedersen; Chandra A Reynolds; Mun-Gwan Hong; Jonathan A Prince; Margaret Gatz; Paul W Dickman; Anna M Bennet Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472
Authors: Sid E O'Bryant; Leigh Johnson; Melissa Edwards; Holly Soares; Michael D Devous; Sarah Ross; Geoffrey Rohlfing; James Hall Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Jaroslav A Hubacek; Anne Peasey; Hynek Pikhart; Petr Stavek; Ruzena Kubinova; Michael Marmot; Martin Bobak Journal: Hum Immunol Date: 2010-01-25 Impact factor: 2.850